ribavirin has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, MM; Levine, AM; Shimodaira, S | 1 |
1 other study(ies) available for ribavirin and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.
Topics: Aged; Antiviral Agents; Cell Line, Tumor; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Ribavirin; Splenic Neoplasms; Viral Load | 2003 |